IMPLICATION of FAST-TRACK PROTOCOL for HIP FRACTURE FIXATION in ALEXANDRIA UNIVERSITY HOSPITALS
Launched by ALEXANDRIA UNIVERSITY · Mar 9, 2025
Trial Information
Current as of May 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, called the IMPLICATION study, is looking at how a fast-track protocol for fixing hip fractures affects patient outcomes. Specifically, it aims to find out if performing surgery within 48 hours of a hip fracture can help reduce the risk of death and other health problems in the month after surgery. Researchers will also be assessing issues like blood clots, breathing problems, memory issues after surgery, how long patients stay in the hospital or intensive care, and whether they need to be readmitted to the hospital.
To participate in this trial, individuals need to be at least 50 years old and have a specific level of physical health (classes I, II, or III). However, those with multiple injuries, certain medication sensitivities, or significant mental health issues, among other factors, will not be eligible. If you meet the criteria and join the study, you can expect to receive timely surgical care and thorough follow-up to monitor your recovery and any complications. This research could provide valuable insights into improving hip fracture treatment and recovery for older adults.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age ≥ 50 years.
- • 2. ASA physical status class I, II or III.
- Exclusion Criteria:
- • 1. Poly-trauma patients.
- • 2. Patients with history of sensitivity to the studied drugs.
- • 3. Psychiatric disease or seizure disorder requiring medication within the previous 2 years.
- • 4. Opioid tolerant patients.
- • 5. Patients with preoperative cognitive dysfunction.
About Alexandria University
Alexandria University, a leading academic institution in Egypt, is dedicated to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on collaboration and interdisciplinary approaches, the university leverages its extensive resources and expertise to conduct rigorous studies that address pressing health challenges. By fostering partnerships with healthcare professionals, industry leaders, and regulatory bodies, Alexandria University aims to contribute to the global body of medical knowledge and enhance the quality of patient care through evidence-based findings.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Alexandria, Egypt, Alexandria, Egypt
Patients applied
Trial Officials
Moustafa Abdelaziz Ahmed, MD
Study Director
Alexandria University
Maher Doghiem, MD
Study Director
Alexandria University
Ahmed Shehab, MD
Study Director
Alexandria University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported